AAPL347.35-3.34 (-0.95%) ▼|ABBV293.12-0.18 (-0.06%) ▼|ABT108.84-1.67 (-1.51%) ▼|ACN254.80+0.43 (+0.17%) ▲|ADBE234.48-2.84 (-1.20%) ▼|AMAT371.94+1.39 (+0.38%) ▲|AMD524.78+16.20 (+3.19%) ▲|AMGN460.83-4.40 (-0.95%) ▼|AMT188.37-0.63 (-0.33%) ▼|AMZN269.10+2.17 (+0.81%) ▲|AVGO328.43+8.95 (+2.80%) ▲|AXP323.01-1.31 (-0.40%) ▼|BA171.76-0.62 (-0.36%) ▼|BAC50.55-0.01 (-0.01%) ▼|BKNG162.13-1.36 (-0.83%) ▼|BLK1,214.60-0.11 (-0.01%) ▼|BMY61.50-0.64 (-1.03%) ▼|BNY150.88-0.35 (-0.23%) ▼|BRK-B578.58+3.33 (+0.58%) ▲|C121.96-0.02 (-0.01%) ▼|CAT576.84-22.04 (-3.68%) ▼|CL98.27+0.33 (+0.34%) ▲|CMCSA24.63+0.12 (+0.47%) ▲|COF195.95-2.63 (-1.32%) ▼|COP134.78+0.31 (+0.23%) ▲|COST1,064.77-1.41 (-0.13%) ▼|CRM212.56-2.38 (-1.11%) ▼|CSCO97.98-0.68 (-0.68%) ▼|CVS86.14+0.89 (+1.05%) ▲|CVX209.68-1.11 (-0.52%) ▼|DE678.69-12.60 (-1.82%) ▼|DHR234.30-0.82 (-0.35%) ▼|DIS118.23-0.89 (-0.75%) ▼|DUK128.33+0.23 (+0.18%) ▲|EMR167.59-1.94 (-1.14%) ▼|FDX315.52-3.32 (-1.04%) ▼|GD364.89+2.82 (+0.78%) ▲|GE331.88-3.66 (-1.09%) ▼|GEV777.95-51.39 (-6.20%) ▼|GILD168.68-0.65 (-0.38%) ▼|GM88.53-1.13 (-1.25%) ▼|GOOG285.32-0.70 (-0.24%) ▼|GOOGL287.50-0.65 (-0.23%) ▼|GS905.48-0.74 (-0.08%) ▼|HD349.94-3.49 (-0.99%) ▼|HON227.10-1.90 (-0.83%) ▼|IBM243.58-0.85 (-0.35%) ▼|INTC58.24-1.13 (-1.90%) ▼|INTU338.66+0.43 (+0.13%) ▲|ISRG444.54-16.03 (-3.48%) ▼|JNJ280.80-1.31 (-0.46%) ▼|JPM342.12+0.04 (+0.01%) ▲|KO96.27+0.24 (+0.25%) ▲|LIN518.77-1.56 (-0.30%) ▼|LLY1,414.70+2.75 (+0.19%) ▲|LMT597.56+9.37 (+1.59%) ▲|LOW229.74-2.36 (-1.02%) ▼|LRCX223.00+1.69 (+0.76%) ▲|MA657.10+1.29 (+0.20%) ▲|MCD281.11-0.33 (-0.12%) ▼|MDLZ66.09-0.36 (-0.53%) ▼|MDT100.90-1.89 (-1.84%) ▼|META642.77+1.40 (+0.22%) ▲|MMM187.39-1.24 (-0.66%) ▼|MO75.93+0.12 (+0.16%) ▲|MRK145.99-2.77 (-1.86%) ▼|MS187.22+0.12 (+0.06%) ▲|MSFT542.90-2.28 (-0.42%) ▼|MU716.24-16.91 (-2.31%) ▼|NEE86.31-0.55 (-0.63%) ▼|NFLX62.69-1.26 (-1.97%) ▼|NKE38.67-1.21 (-3.03%) ▼|NOW100.07-2.69 (-2.61%) ▼|NVDA168.56-10.11 (-5.66%) ▼|ORCL119.07-0.72 (-0.60%) ▼|PEP142.17+0.29 (+0.20%) ▲|PFE29.00-0.23 (-0.79%) ▼|PG169.03+0.71 (+0.42%) ▲|PLTR167.79-1.41 (-0.83%) ▼|PM194.31+1.19 (+0.62%) ▲|QCOM169.99-1.48 (-0.86%) ▼|RTX198.66+2.35 (+1.20%) ▲|SBUX109.18-0.27 (-0.24%) ▼|SCHW93.33+0.60 (+0.64%) ▲|SO93.22-0.35 (-0.37%) ▼|SPG232.34-0.67 (-0.29%) ▼|T21.81+0.01 (+0.05%) ▲|TMO714.98-6.65 (-0.92%) ▼|TMUS166.71-2.00 (-1.19%) ▼|TSLA376.60-1.45 (-0.38%) ▼|TXN295.32-0.41 (-0.14%) ▼|UBER69.48-1.69 (-2.38%) ▼|UNH400.23+2.61 (+0.66%) ▲|UNP297.59+0.58 (+0.20%) ▲|UPS109.87-1.10 (-0.99%) ▼|USB60.44-0.52 (-0.85%) ▼|V422.07+0.69 (+0.16%) ▲|VZ46.03-0.03 (-0.07%) ▼|WFC85.63+0.14 (+0.16%) ▲|WMT125.58-0.08 (-0.06%) ▼|XOM163.69-1.05 (-0.63%) ▼|AAPL347.35-3.34 (-0.95%) ▼|ABBV293.12-0.18 (-0.06%) ▼|ABT108.84-1.67 (-1.51%) ▼|ACN254.80+0.43 (+0.17%) ▲|ADBE234.48-2.84 (-1.20%) ▼|AMAT371.94+1.39 (+0.38%) ▲|AMD524.78+16.20 (+3.19%) ▲|AMGN460.83-4.40 (-0.95%) ▼|AMT188.37-0.63 (-0.33%) ▼|AMZN269.10+2.17 (+0.81%) ▲|AVGO328.43+8.95 (+2.80%) ▲|AXP323.01-1.31 (-0.40%) ▼|BA171.76-0.62 (-0.36%) ▼|BAC50.55-0.01 (-0.01%) ▼|BKNG162.13-1.36 (-0.83%) ▼|BLK1,214.60-0.11 (-0.01%) ▼|BMY61.50-0.64 (-1.03%) ▼|BNY150.88-0.35 (-0.23%) ▼|BRK-B578.58+3.33 (+0.58%) ▲|C121.96-0.02 (-0.01%) ▼|CAT576.84-22.04 (-3.68%) ▼|CL98.27+0.33 (+0.34%) ▲|CMCSA24.63+0.12 (+0.47%) ▲|COF195.95-2.63 (-1.32%) ▼|COP134.78+0.31 (+0.23%) ▲|COST1,064.77-1.41 (-0.13%) ▼|CRM212.56-2.38 (-1.11%) ▼|CSCO97.98-0.68 (-0.68%) ▼|CVS86.14+0.89 (+1.05%) ▲|CVX209.68-1.11 (-0.52%) ▼|DE678.69-12.60 (-1.82%) ▼|DHR234.30-0.82 (-0.35%) ▼|DIS118.23-0.89 (-0.75%) ▼|DUK128.33+0.23 (+0.18%) ▲|EMR167.59-1.94 (-1.14%) ▼|FDX315.52-3.32 (-1.04%) ▼|GD364.89+2.82 (+0.78%) ▲|GE331.88-3.66 (-1.09%) ▼|GEV777.95-51.39 (-6.20%) ▼|GILD168.68-0.65 (-0.38%) ▼|GM88.53-1.13 (-1.25%) ▼|GOOG285.32-0.70 (-0.24%) ▼|GOOGL287.50-0.65 (-0.23%) ▼|GS905.48-0.74 (-0.08%) ▼|HD349.94-3.49 (-0.99%) ▼|HON227.10-1.90 (-0.83%) ▼|IBM243.58-0.85 (-0.35%) ▼|INTC58.24-1.13 (-1.90%) ▼|INTU338.66+0.43 (+0.13%) ▲|ISRG444.54-16.03 (-3.48%) ▼|JNJ280.80-1.31 (-0.46%) ▼|JPM342.12+0.04 (+0.01%) ▲|KO96.27+0.24 (+0.25%) ▲|LIN518.77-1.56 (-0.30%) ▼|LLY1,414.70+2.75 (+0.19%) ▲|LMT597.56+9.37 (+1.59%) ▲|LOW229.74-2.36 (-1.02%) ▼|LRCX223.00+1.69 (+0.76%) ▲|MA657.10+1.29 (+0.20%) ▲|MCD281.11-0.33 (-0.12%) ▼|MDLZ66.09-0.36 (-0.53%) ▼|MDT100.90-1.89 (-1.84%) ▼|META642.77+1.40 (+0.22%) ▲|MMM187.39-1.24 (-0.66%) ▼|MO75.93+0.12 (+0.16%) ▲|MRK145.99-2.77 (-1.86%) ▼|MS187.22+0.12 (+0.06%) ▲|MSFT542.90-2.28 (-0.42%) ▼|MU716.24-16.91 (-2.31%) ▼|NEE86.31-0.55 (-0.63%) ▼|NFLX62.69-1.26 (-1.97%) ▼|NKE38.67-1.21 (-3.03%) ▼|NOW100.07-2.69 (-2.61%) ▼|NVDA168.56-10.11 (-5.66%) ▼|ORCL119.07-0.72 (-0.60%) ▼|PEP142.17+0.29 (+0.20%) ▲|PFE29.00-0.23 (-0.79%) ▼|PG169.03+0.71 (+0.42%) ▲|PLTR167.79-1.41 (-0.83%) ▼|PM194.31+1.19 (+0.62%) ▲|QCOM169.99-1.48 (-0.86%) ▼|RTX198.66+2.35 (+1.20%) ▲|SBUX109.18-0.27 (-0.24%) ▼|SCHW93.33+0.60 (+0.64%) ▲|SO93.22-0.35 (-0.37%) ▼|SPG232.34-0.67 (-0.29%) ▼|T21.81+0.01 (+0.05%) ▲|TMO714.98-6.65 (-0.92%) ▼|TMUS166.71-2.00 (-1.19%) ▼|TSLA376.60-1.45 (-0.38%) ▼|TXN295.32-0.41 (-0.14%) ▼|UBER69.48-1.69 (-2.38%) ▼|UNH400.23+2.61 (+0.66%) ▲|UNP297.59+0.58 (+0.20%) ▲|UPS109.87-1.10 (-0.99%) ▼|USB60.44-0.52 (-0.85%) ▼|V422.07+0.69 (+0.16%) ▲|VZ46.03-0.03 (-0.07%) ▼|WFC85.63+0.14 (+0.16%) ▲|WMT125.58-0.08 (-0.06%) ▼|XOM163.69-1.05 (-0.63%) ▼|
13.3 C
New York
Tuesday, November 10, 2026

Tag: source

newsFORsourcecompanycontentinformationreleases1IT

Metamorphoses | 2025 CAA Graduation Season

HANGZHOU, China, June 10, 2025 /CNW/ -- As 2025 approaches its most vibrant and life-affirming season, the China Academy of Art (CAA) has already...

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration

Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in their Phase Ib clinical trial of its lead candidate HRX-215. The trial is evaluating the safety and efficacy of HRX-215, an orally available small-molecule inhibitor of MKK4, in patients undergoing partial liver resection due to liver metastases deriving from colorectal cancer. HXR-215 is designed to treat advanced-stage liver disease by increasing the regenerative capacity of hepatocytes. An initial data readout is planned for the second half of 2025.

NVIDIA Powers Europe’s Fastest Supercomputer

NVIDIA Grace Hopper Platform Boosts Simulation and Training on Jülich’s JUPITER Supercomputer to Drive Europe’s Scientific Breakthroughs at Exascale Speed 
NVIDIA Grace Hopper Platform Boosts Simulation and Training on Jülich’s JUPITER Supercomputer to Drive Europe’s Scientific Breakthroughs at Exascale Speed

World Precision Instruments and SynVivo Announce Launch of EVOM™ Chip-A Breakthrough Multiplex TEER System Enabling Real-Time Organ-on-Chip Monitoring

SARASOTA, Fla., June 10, 2025 /PRNewswire/ -- World Precision Instruments (WPI), the global leader in transepithelial electrical resistance (TEER) technology, in collaboration with SynVivo, a...

Mullen Automotive Finalizes Settlement with GEM Group

Company moves forward accelerating its business objectives 
Company moves forward accelerating its business objectives

NETSOL Secures Product Expansion with UK Brokerage Charles and Dean

Charles and Dean, a leading UK finance broker, has expanded its adoption of NETSOL’s Transcend Marketplace by selecting an end-to-end origination portal.

Prepayments, Realkredit Danmark A/S

Company Announcement No 50/2025  

Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy

LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United States and Europe,...

Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel Advisors – Leading...

NEW DELHI, June 10, 2025 /PRNewswire/ -- The Global Clinical Workflow Management Software Market size is set to experience significant growth in the coming years....

Europe Spinal Navigation Market Report 2025: Equipment-as-a-Service Models Gain Traction as Hospitals Seek Cost-Effective Navigation Solutions – Forecast to 2032

The Europe spinal navigation market, valued at $192.1 million in 2023, is projected to reach $754.7 million by 2032, growing at a CAGR of 16.42%. Advanced technologies enhance spine surgery accuracy, patient safety, and outcomes despite high investment costs. Overcoming financial and regulatory hurdles is key for widespread adoption. 
The Europe spinal navigation market, valued at $192.1 million in 2023, is projected to reach $754.7 million by 2032, growing at a CAGR of 16.42%. Advanced technologies enhance spine surgery accuracy, patient safety, and outcomes despite high investment costs. Overcoming financial and regulatory hurdles is key for widespread adoption.

Glo Fiber Expands Service and Opens New Retail Location in Williamsburg, Virginia

EDINBURG, Va., June 10, 2025 (GLOBE NEWSWIRE) -- Glo Fiber, powered by Shenandoah Telecommunications Company (“Shentel”) (Nasdaq: SHEN), has opened a new Williamsburg, Virginia retail store for ultra-fast fiber internet service. A grand opening event is scheduled for June 12th from 4 p.m. to 6 p.m. in Midtown Row on Monticello Avenue. The Tide 92.3 FM will be appearing at the store with special Glo Fiber offers and chances to win concert tickets and other prizes.

XTransfer Partners with BNP Paribas to Simplify Cross-Border Payments at Money20/20 Europe

AMSTERDAM, June 10, 2025 /PRNewswire/ -- XTransfer, the world's leading and China's No.1 B2B cross-border trade payment platform, and BNP Paribas, the European Union's leading...

What Holds the Internet Together and Why It’s Now at Risk

A new report from ICANN and the Internet Society details how the Internet Governance Forum has supported a stable and secure Internet—and why that model...

Alm. Brand A/S – Weekly report on share buybacks

Alm. Brand A/S share buy-back program

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSource

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers